HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a 'Buy' rating on Rockwell Medical (NASDAQ:RMTI) and maintained a price target of $11.
September 28, 2023 | 11:42 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rockwell Medical's stock may see positive movement as HC Wainwright & Co. maintains a 'Buy' rating and a price target of $11.
Analyst ratings often influence the stock market. A 'Buy' rating suggests that the analyst believes the stock will perform well in the future. The maintained price target of $11 indicates that the analyst believes the stock is undervalued at its current price, which could lead to increased buying pressure and a potential increase in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100